Evotec
Jan Willem Vogel is a seasoned professional in the field of chemistry and information technology, currently serving as a Senior IT Architect and Team Lead for Distribution & Trade Regulations at Evotec since April 2019. Vogel's prior experience includes a role as a Chemiker at JOB Kontor GmbH from July 2018 to March 2019 and as a Wissenschaftlicher Mitarbeiter at Universität Hamburg from January 2012 to June 2017. Education encompasses a Doktor in Chemie from the University of Hamburg, earned in October 2021, complemented by a Master of Science in Chemie and a Bachelor of Science in Chemie, both from the same institution. Additionally, Vogel is pursuing further studies at Leipzig University since October 2020.
This person is not in the org chart
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.